November 22nd 2024
A new study shows that COVID-19 infection significantly increases the risk of exacerbation in patients with myasthenia gravis (MG).
Contingency Management in a Perinatal Substance Exposure Clinic
Project CARA, a perinatal substance exposure clinic, has implemented a contingency management program that targets appointment attendance for patients with any use disorder, regardless of substance or urine drug screen results.
Read More
Mandatory Switch Policies Drive Biosimilar Uptake, Reduce Costs
June 2nd 2023Abstracts presented at EULAR 2023 highlighted the impact that a mandatory switching policy had on biosimilar uptake in British Columbia, Canada, and the lack of uptake when no such policy was in place in the United States.
Read More
Unmet Needs in Myasthenia Gravis Are Numerous, Says Dr James Howard
June 2nd 2023Unmet needs include both improved myasthenia gravis treatments as well as a way to monitor progression of the disease, said James F. Howard, Jr, MD, professor of neurology at the University of North Carolina at Chapel Hill.
Watch
Contemporary Care Patterns in the Management of Small Renal Masses
An investigation of management patterns after initial radiographic diagnosis of small renal masses showed that early urologist referral was associated with guideline-concordant care.
Read More
Fostering Primary Care Use May Hold Key to Value and Quality
May 24th 2023At the 2023 Greater Philadelphia Business Coalition on Health, panelists described the ways their organizations are promoting access to primary care in hopes that it can be part of the progress toward achieving the Quadruple Aim of lower costs, better outcomes, patient satisfaction, and clinician experience.
Read More
Provider Barriers in Uptake of Biosimilars: Case Study on Filgrastim
Previous studies have found modest uptake of biosimilars in both commercial and Medicare populations. This study finds that the uptake varies between the rural and urban provider settings.
Read More
Managing Total Knee Replacement Under Value-Based Payments
This article describes the approach that a large primary care group at risk for value-based payments chose to deploy in managing clinical and financial outcomes of knee osteoarthritis jointly with orthopedic surgeons.
Read More
Step Therapy Requirements Are Worsening, Says Dr James Howard
May 19th 2023Myasthenia gravis expert James F. Howard, Jr, MD, professor of neurology at the University of North Carolina at Chapel Hill, explains the burdens that step therapy places on patients with rare diseases and their providers.
Watch
Communication, Teamwork Can Foster Resilience, Says Dr Lee Norman
May 14th 2023The best leaders are those who foster open communication, says Lee A. Norman, MD, MHS, MBA, who appeared at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event on population health in Kansas City, Missouri.
Watch
Atopic Dermatitis Treatment Equally Effective in Extrinsic, Intrinsic Subtypes
May 12th 2023Patients who have extrinsic (EAD) or intrinsic atopic dermatitis (IAD) serve to benefit equally from dupilumab, even when considering immunoglobulin E levels, which are elevated in EAD but remain normal in IAD.
Read More
Deliberate Learning Can Help Providers Adapt, Says Dr Lee Norman
May 7th 2023Keeping up-to-date on information, whether it is about clinical matters or information systems, is critical to a deliberate learning mindset that is beneficial to health care providers, says Lee A. Norman, MD, MHS, MBA, the senior medical director for Optum Care Kansas City.
Watch